Replies to post #157596 on Biotech Values

[mcbio]

But in essence not far from my general disposition: supremely useful in the lab, but hard to live up to that type of efficacy in the clinic.

I.e., bloated valuation at ~$500M market cap?

[vinmantoo]

poorgradstudent, I agree with you regarding SGMO.

[DewDiligence]

SGMO (8.22) -7% on less than stellar HIV data at American Society of Gene and Cell Therapy:

http://finance.yahoo.com/news/sangamo-biosciences-presents-clinical-data-140000609.html